Investor Information - Abzena

Our Vision

To improve the quality of healthcare by providing innovative discovery, development and manufacturing solutions to enable superior therapeutic options for patients

Our Mission

To be the preferred provider of specialist services and proprietary technologies to enable the development and commercialisation of better biopharmaceuticals products

Our Mission

To actively engage with innovators to accelerate the development process for innovative and differentiated products

Our Mission

To sustain a strong reputation as an innovator in the field of biopharmaceutical development

Investor Relations

Abzena is a revenue generating life sciences group with its headquarters in the UK and two sites in the US. The Group offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals.

About Us

Share Price

  • ...
  • ...

  • ...

Results & Presentations

The Company's Interims, full year and annual reports and available here.

Abzena Inside

Abzena has over 40 technology licence and option agreements covering its proprietary technologies. Read More

Contact Investor Relations


Our Latest News and Events

Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.

Load More

Annual Report 2017

“The past 12 months have been a combination of integration and preparing the Group for significant growth. Integration of our US sites into the Abzena group is starting to deliver the expected revenue synergies. The business now has a solid platform from which to expand."

John Burt
Chief Executive Officer

Download the 2017 Annual Report